“Efficacy of Bevacizumab to Reduce Lid Margin Vascularity and Alteration in Tear Film Status”. 2021. Annals of King Edward Medical University, vol. 27, no. Special Issue (Jul-Sep), Nov. 2021, pp. 368-71, doi:10.21649/akemu.v27iSpecial Issue (Jul-Sep).4656.